281 related articles for article (PubMed ID: 21131235)
1. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
2. Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.
Tabori U; Mark Z; Amariglio N; Etzioni A; Golan H; Biloray B; Toren A; Rechavi G; Dalal I
Clin Genet; 2004 Apr; 65(4):322-6. PubMed ID: 15025726
[TBL] [Abstract][Full Text] [Related]
3. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
Niehues T; Perez-Becker R; Schuetz C
Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
[TBL] [Abstract][Full Text] [Related]
4. Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.
Dalal I; Tabori U; Bielorai B; Golan H; Rosenthal E; Amariglio N; Rechavi G; Toren A
Clin Immunol; 2005 Apr; 115(1):70-3. PubMed ID: 15870023
[TBL] [Abstract][Full Text] [Related]
5. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
[TBL] [Abstract][Full Text] [Related]
6. Human RAG mutations: biochemistry and clinical implications.
Notarangelo LD; Kim MS; Walter JE; Lee YN
Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
[TBL] [Abstract][Full Text] [Related]
7. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
8. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
[TBL] [Abstract][Full Text] [Related]
9. RAG-dependent primary immunodeficiencies.
Sobacchi C; Marrella V; Rucci F; Vezzoni P; Villa A
Hum Mutat; 2006 Dec; 27(12):1174-84. PubMed ID: 16960852
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome.
Dalal I; Tasher D; Somech R; Etzioni A; Garti BZ; Lev D; Cohen S; Somekh E; Leshinsky-Silver E
Clin Immunol; 2011 Sep; 140(3):284-90. PubMed ID: 21624848
[TBL] [Abstract][Full Text] [Related]
11. [Hypomorphic RAG1 mutations and CMV infection: a new phenotype of severe combined immunodeficiency].
Le Deist F; de Villartay JP; Lim A; Déchanet J; Fischer A
Med Sci (Paris); 2006 Mar; 22(3):239-40. PubMed ID: 16527199
[No Abstract] [Full Text] [Related]
12. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
[TBL] [Abstract][Full Text] [Related]
13. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
14. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.
Villa A; Sobacchi C; Notarangelo LD; Bozzi F; Abinun M; Abrahamsen TG; Arkwright PD; Baniyash M; Brooks EG; Conley ME; Cortes P; Duse M; Fasth A; Filipovich AM; Infante AJ; Jones A; Mazzolari E; Muller SM; Pasic S; Rechavi G; Sacco MG; Santagata S; Schroeder ML; Seger R; Strina D; Ugazio A; Väliaho J; Vihinen M; Vogler LB; Ochs H; Vezzoni P; Friedrich W; Schwarz K
Blood; 2001 Jan; 97(1):81-8. PubMed ID: 11133745
[TBL] [Abstract][Full Text] [Related]
15. Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.
Tirosh I; Yamazaki Y; Frugoni F; Ververs FA; Allenspach EJ; Zhang Y; Burns S; Al-Herz W; Noroski L; Walter JE; Gennery AR; van der Burg M; Notarangelo LD; Lee YN
J Allergy Clin Immunol; 2019 Feb; 143(2):726-735. PubMed ID: 29772310
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in understanding RAG deficiencies.
Gennery A
F1000Res; 2019; 8():. PubMed ID: 30800289
[TBL] [Abstract][Full Text] [Related]
17. Novel RAG1 mutation in a case of severe combined immunodeficiency.
Zhang J; Quintal L; Atkinson A; Williams B; Grunebaum E; Roifman CM
Pediatrics; 2005 Sep; 116(3):e445-9. PubMed ID: 16061569
[TBL] [Abstract][Full Text] [Related]
18. IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID.
Safaei S; Pourpak Z; Moin M; Houshmand M
Iran J Allergy Asthma Immunol; 2011 Jun; 10(2):129-32. PubMed ID: 21625022
[TBL] [Abstract][Full Text] [Related]
19. [Clinical phenotype and gene diagnostic analysis of Omenn syndrome].
Wang YQ; Cui YX; Feng J
Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):64-8. PubMed ID: 23527934
[TBL] [Abstract][Full Text] [Related]
20. Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens.
Geier CB; Piller A; Linder A; Sauerwein KM; Eibl MM; Wolf HM
PLoS One; 2015; 10(7):e0133220. PubMed ID: 26186701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
